This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

  1. Education
  2. Source: Campus Sanofi
  3. 1 Jun 2024
2 min

EBMT 2024: Expanding the cGvHD treatment paradigm with novel therapeutics

Author: Corey Cutler

Editorial Team

Expanding the treatment paradigm with novel therapeutics

Length: 8 mins

This video introduces novel therapies for chronic GvHD treatment, an overview of the MOAs, and an overiew of the key data from complete clinical trials.

Advances in the biology of chronic GvHD

Frontline treatment of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management

1/8

Advances in the biology of chronic GvHD

Frontline treatment of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management

1/3
Rezurock logo with man

Get the latest updates about REZUROCK

ROCKstar Study

Download ROCKstar study summary. 

1/2
Rezurock logo with man

Get the latest updates about REZUROCK

ROCKstar Study

Download ROCKstar study summary. 

Get in touch with the Transplant Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2402250 (v2.0) Date of Preparation: May 2025